Browse medicines, page 30 of 37

Use listed on the medicine record

Chagas disease (American Trypanosomiasis) caused by Trypanosoma cruzi [see Clinical Studies ( 14 )]

Use listed on the medicine record

Metastatic prostate cancer

Use listed on the medicine record

Mild-to-moderate coronavirus disease 2019

Use listed on the medicine record

Diarrhea caused by Giardia lamblia or Cryptosporidium parvum

Use listed on the medicine record

Active duodenal ulcer

Use listed on the medicine record

Adults and children 12 years of age and over: apply to affected area not more than 3 to 4 times daily. Children under 12 years of age: do not use, consult a doctor For easy application: partially peel back protective film and apply exposed patch to the site of pain. Carefully remove remaining film while pressing patch to skin for secure adhesion.

Use listed on the medicine record

Moderate acne vulgaris

Use listed on the medicine record

Helps provide mimial protection agains sunburn. Higher SPF gives more sunburn protection. For skin that sunburns minimally.

Use listed on the medicine record

Mild to moderate infections (unless otherwise indicated) caused by susceptible strains of the designated microorganisms in the i

Use listed on the medicine record

Acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate

Use listed on the medicine record

USAGE After cleansing, hold the bottle 15-20 cm awayfrom your face, close your eyes, and gently mistevenly over the skin. Allow it to absorb naturallyor lightly pat for better penetration. Follow withyour regular skincare routine.

Use listed on the medicine record

Acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option

Use listed on the medicine record

for the temporary relief of: • bloating • water-weight gain • swelling • full feeling associated with the premenstrual and menstrual periods

Use listed on the medicine record

Moderate or severe hypercalcemia associated with malignancy, with or without bone metastases

Use listed on the medicine record

INDICATIONS & USAGE 1.1 Chronic Kidney Disease Stages 3 and 4 Paricalcitol Capsules are indicated in adults for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4. Pediatric use information for patients 10 to 16 years of age is approved for AbbVie Inc.’s Zemplar (Paricalcitol) capsules. However, due to AbbVie Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

Use listed on the medicine record

Intestinal amebiasis–acute and chronic

Use listed on the medicine record

The treatment of adults

Use listed on the medicine record

Recurrent herpes labialis

Use listed on the medicine record

Therapy Penicillin G Potassium for Injection is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin G.

Use listed on the medicine record

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bicillin C-R and other antibacterial drugs, Bicillin C-R should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Use listed on the medicine record

Parenteral Sedatives. Hypnotics, for the short-term treatment of insomnia, since they appear to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks. (See " Clinical Pharmacology " section.) Preanesthetics. Anticonvulsant, in anesthetic doses, in the emergency control of certain acute convulsive episodes, e.g., those associated with status epilepticus, cholera, eclampsia, meningitis, tetanus, and toxic reactions to strychnine or local anesthetics.

Use listed on the medicine record

Bladder pain or discomfort associated with interstitial cystitis

Use listed on the medicine record

Apply liberally 15 minutes before sun exposure. Reapply at least every 2 hours. Use a water resistant sunscreen if swimming or sweating. Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. — 2 p.m. wear long-sleeve shirts, pants, hats, and sunglasses.

Use listed on the medicine record

INDICATIONS: May temporarily relieve weakness and exhaustion, minor abdominal cramps, bloating, and vomiting.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Use listed on the medicine record

Best for Temporarily relieves occasional weakness and exhaustion caused by loss of vital fluids. Temporarily supports memory and concentration.*

Use listed on the medicine record

Pimecrolimus cream, 1% is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adults and children 2 years of age and older, who have failed to respond adequately to other topical prescription treatments, or when those treatments are not advisable. Pimecrolimus c ream, 1% is not indicated for use in children less than 2 years of age [see Warnings and Precautions (5.1) , Use in Specific Populations (8.4) ].

Use listed on the medicine record

The suppression of motor and phonic tics

Use listed on the medicine record

Pindolol tablets are indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic.

Use listed on the medicine record

Appendicitis (complicated by rupture or abscess) and peritonitis caused by beta-lactamase producing isolates of Escherichia coli or the foll

Use listed on the medicine record

Idiopathic pulmonary fibrosis

Use listed on the medicine record

JAYPIRCA ® is a kinase inhibitor indicated for the treatment of: Adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor. ( 1.1 ). This indication is approved under accelerated approval based on response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Use listed on the medicine record

PIVYA is a penicillin class antibacterial indicated for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus . ( 1.1 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of PIVYA and other antibacterial drugs, PIVYA should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

Use listed on the medicine record

Plerixafor injection is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) or multiple myeloma (MM). Plerixafor injection, a hematopoietic stem cell mobilizer, is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma or multiple myeloma. ( 1 )

Use listed on the medicine record

The topical treatment of external genital warts

Use listed on the medicine record

VARITHENA (polidocanol injectable foam) is indicated for the treatment of incompetent great saphenous veins, accessory saphenous veins, and visible varicosities of the great saphenous vein (GSV) system above and below the knee. VARITHENA improves the symptoms of superficial venous incompetence and the appearance of visible varicosities. VARITHENA (polidocanol injectable foam) is a sclerosing agent indicated for the treatment of incompetent great saphenous veins, accessory saphenous veins, and visible varicosities of the great saphenous vein (GSV) system above and below the knee.

Use listed on the medicine record

For underarm, privates, and beyond cleansing to help reduce odor and rfesh skin. For use when showering or changing clothes is not available.

Use listed on the medicine record

Burning, irritation, and discomfort due to dryness of the eye or exposure to wind or sun for use as a protectant against further irritation

Use listed on the medicine record

Symptoms related to toxicity, such as headache, fatigue, body aches, and skin complaints

Use listed on the medicine record

Discomfort due to minor irritations of the eye, or to exposure to wind or sun

Use listed on the medicine record

PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. PONVORY is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )